Fesomersen

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameFesomersen
Drug Alias NameION-957943IONIS-FXI-LRxBAY-2976217
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionCoagulation factor XI inhibitors
TargetsCoagulation factor XI
Therapy Area/IndicationsThromboembolismNephrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[16] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesBayer AGBayer Healthcare Company Ltd
Inactive CompaniesIonis Pharmaceuticals Inc
Active IndicationsThromboembolismNephrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A